Hans‐Michael Behrens

2.2k total citations
55 papers, 1.7k citations indexed

About

Hans‐Michael Behrens is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hans‐Michael Behrens has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 19 papers in Molecular Biology. Recurrent topics in Hans‐Michael Behrens's work include Gastric Cancer Management and Outcomes (19 papers), Genetic factors in colorectal cancer (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Hans‐Michael Behrens is often cited by papers focused on Gastric Cancer Management and Outcomes (19 papers), Genetic factors in colorectal cancer (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Hans‐Michael Behrens collaborates with scholars based in Germany, United Kingdom and Latvia. Hans‐Michael Behrens's co-authors include Christoph Röcken, Sandra Krüger, Christine Böger, Viktoria S. Warneke, Micaela Mathiak, Holger Kalthoff, Jochen Haag, Thomas Becker, Éva Simon and Matthias Dottermusch and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Hans‐Michael Behrens

55 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans‐Michael Behrens Germany 21 848 642 532 392 265 55 1.7k
Sandra Krüger Germany 20 1.0k 1.2× 590 0.9× 645 1.2× 319 0.8× 277 1.0× 63 1.8k
Christine Böger Germany 16 708 0.8× 479 0.7× 232 0.4× 307 0.8× 221 0.8× 23 1.2k
Karl Dhaene Belgium 18 1.1k 1.3× 810 1.3× 382 0.7× 631 1.6× 199 0.8× 30 2.1k
Dakeun Lee South Korea 23 581 0.7× 346 0.5× 603 1.1× 304 0.8× 192 0.7× 74 1.4k
Arne Östman Sweden 23 915 1.1× 720 1.1× 928 1.7× 133 0.3× 239 0.9× 36 2.2k
Inge H. Briaire‐de Bruijn Netherlands 29 714 0.8× 1.1k 1.7× 1.0k 1.9× 242 0.6× 274 1.0× 65 2.7k
Naoki Takahashi Japan 17 841 1.0× 435 0.7× 515 1.0× 298 0.8× 150 0.6× 89 1.6k
So Young Kang South Korea 29 895 1.1× 634 1.0× 714 1.3× 366 0.9× 203 0.8× 92 2.1k
Tomonori Kawasaki Japan 22 938 1.1× 340 0.5× 775 1.5× 356 0.9× 175 0.7× 121 2.1k
Yoonjin Kwak South Korea 21 949 1.1× 437 0.7× 339 0.6× 248 0.6× 216 0.8× 79 1.4k

Countries citing papers authored by Hans‐Michael Behrens

Since Specialization
Citations

This map shows the geographic impact of Hans‐Michael Behrens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Michael Behrens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Michael Behrens more than expected).

Fields of papers citing papers by Hans‐Michael Behrens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Michael Behrens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Michael Behrens. The network helps show where Hans‐Michael Behrens may publish in the future.

Co-authorship network of co-authors of Hans‐Michael Behrens

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Michael Behrens. A scholar is included among the top collaborators of Hans‐Michael Behrens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Michael Behrens. Hans‐Michael Behrens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heckl, S., Hans‐Michael Behrens, A Bernsmeier, et al.. (2025). Worse survival of hepatocellular cancer patients with membranous insulin receptor overexpression. Scientific Reports. 15(1). 1209–1209. 2 indexed citations
2.
Simon, P L, Hans‐Michael Behrens, Arnt V. Kristen, & Christoph Röcken. (2024). Myocardial inflammatory cells in cardiac amyloidosis. Scientific Reports. 14(1). 23313–23313. 7 indexed citations
3.
Behrens, Hans‐Michael, et al.. (2023). MDM2 amplification is rare in gastric cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(6). 795–807. 1 indexed citations
4.
Behrens, Hans‐Michael, Sandra Krüger, S. Heckl, et al.. (2023). LAG3 in gastric cancer: it’s complicated. Journal of Cancer Research and Clinical Oncology. 149(12). 10797–10811. 10 indexed citations
5.
Veldhuizen, Gregory Patrick, Christoph Röcken, Hans‐Michael Behrens, et al.. (2023). Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study. Gastric Cancer. 26(5). 708–720. 13 indexed citations
6.
Krüger, Sandra, et al.. (2023). SMARCA4 and SMARCE1 in gastric cancer: Correlation with ARID1A, and microsatellite stability, and SMARCE1/ERBB2 co‐amplification. Cancer Medicine. 12(9). 10423–10437. 6 indexed citations
7.
Behrens, Hans‐Michael, et al.. (2023). Exploration of the Tumour Biological Significance of PCLO in Gastric Cancer: Results from a Large Central European Cohort. Pathobiology. 91(3). 187–195. 2 indexed citations
8.
Röcken, Christoph, Arne Traulsen, Hans‐Michael Behrens, et al.. (2021). Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine. Genome Medicine. 13(1). 177–177. 24 indexed citations
9.
Behrens, Hans‐Michael, et al.. (2020). p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort. Human Pathology. 105. 53–66. 19 indexed citations
10.
11.
12.
Behrens, Hans‐Michael, et al.. (2019). Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response. Disease Markers. 2019. 1–15. 8 indexed citations
13.
Dottermusch, Matthias, et al.. (2019). Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 475(5). 563–571. 95 indexed citations
14.
Behrens, Hans‐Michael, et al.. (2019). Sexual dimorphism in gastric cancer: tumor-associated neutrophils predict patient outcome only for women. Journal of Cancer Research and Clinical Oncology. 146(1). 53–66. 19 indexed citations
15.
Stuhlmann‐Laeisz, Christiane, Ute Hegenbart, Johanna Nattenmüller, et al.. (2018). Local vs. systemic pulmonary amyloidosis—impact on diagnostics and clinical management. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 473(5). 627–637. 30 indexed citations
16.
Wilhelm, Franziska, Éva Simon, Christine Böger, et al.. (2017). Novel Insights into Gastric Cancer: Methylation of R-spondins and Regulation of LGR5 by SP1. Molecular Cancer Research. 15(6). 776–785. 14 indexed citations
17.
Gutting, Tobias, Klaus‐Peter Janssen, Hans‐Michael Behrens, et al.. (2016). Subcellular compartmentalization of docking protein-1 contributes to progression in colorectal cancer. EBioMedicine. 8. 159–172. 16 indexed citations
18.
Heß, Katharina, Christine Böger, Hans‐Michael Behrens, & Christoph Röcken. (2014). Correlation between the expression of integrins in prostate cancer and clinical outcome in 1284 patients. Annals of Diagnostic Pathology. 18(6). 343–350. 24 indexed citations
19.
Warneke, Viktoria S., Hans‐Michael Behrens, Jochen Haag, et al.. (2013). Prognostic and Putative Predictive Biomarkers of Gastric Cancer for Personalized Medicine. Diagnostic Molecular Pathology. 22(3). 127–137. 47 indexed citations
20.
Simon, Éva, Christine Böger, Hans‐Michael Behrens, et al.. (2012). The Spatial Distribution of LGR5+ Cells Correlates With Gastric Cancer Progression. PLoS ONE. 7(4). e35486–e35486. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandra Krüger Breakdown of academic impact, for papers by Christine Böger Breakdown of academic impact, for papers by Karl Dhaene Breakdown of academic impact, for papers by Dakeun Lee Breakdown of academic impact, for papers by Arne Östman Breakdown of academic impact, for papers by Inge H. Briaire‐de Bruijn Breakdown of academic impact, for papers by Naoki Takahashi Breakdown of academic impact, for papers by So Young Kang Breakdown of academic impact, for papers by Tomonori Kawasaki Breakdown of academic impact, for papers by Yoonjin Kwak
Rankless by CCL
2026